Monday, May 15, 2023

US investor Janus Henderson cut PharmEasy valuation by half to $2.8 billion

The global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, which would translate to an approximate valuation of around $2.8 billion as of December 31, 2022.

from Tech-Economic Times https://ift.tt/cKLOgj7
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

OpenAI Foundation outlines $1 billion push, expands leadership team

OpenAI has committed at least $1 billion over the next year as part of recapitalisation efforts for its Foundation. The investment is aimed ...